Business July 7, 2020
Novavax receives $1.6 billion funding for COVID-19 vaccine development
Novavax (NASDAQ: NVAX) announced that it received $1.6 funding for the development of a vaccine for COVID-19, which continues to…
FOLLOW US
Recent Posts
Arizona
January 11, 2025
Kelly Warner Law Firm Blames USA Herald for Arizona Bar Investigation
Arizona
December 12, 2024
Arizona Bar Opens Investigation on Attorney Aaron Kelly
America
March 20, 2026
KP George Money Laundering Trial Ends in Conviction
America
March 20, 2026
Ohio Family $22.5M Award: Jury Finds Employer’s Decision Led to Newborn’s Death
America
March 20, 2026
Loyola Student Shooting: Campus Grieves After Deadly Beach Attack
America
March 20, 2026
Teen Death in ICE Detention Center Sparks Outcry and Investigation
America
March 20, 2026